Please login or register first to view this content.
Ophthalmic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Lotemax SM Now Available for Post-Op Ocular Pain and Inflammation
First-of-its-Kind Contact Lens With Faster Light Adaptation Coming Soon
Dexycu Now Available for Treatment of Post-Op Ocular Inflammation
Rocklatan Approved to Reduce IOP in Patients With Open-Angle Glaucoma or Ocular Hypertension
Lotemax SM Approved for Post-Op Inflammation, Pain Following Ocular Surgery
Xipere Under FDA Review for Macular Edema Associated With Uveitis
Yutiq Now Available for Chronic Non-Infectious Posterior Segment Uveitis
USPSTF: Final Rec on Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum
Managing Traumatic Hyphema: Medical Interventions Investigated
Expanding Pharmacist Practice Scope Could Reduce ED Overcrowding
Statin Therapy Reduces Risk for Diabetic Retinopathy in T2DM
Inveltys Now Available for Post-Op Ocular Pain, Inflammation
RNA-Based Oligonucleotide Gets Fast-Tracked for Usher Syndrome Type 2
Minimally Invasive Surgery Works Well for Detached Retina
Dextenza Approved for Ocular Pain Following Ophthalmic Surgery
Myo-Inositol Does Not Reduce Retinopathy of Prematurity
Humira Approved for the Treatment of Pediatric Uveitis
NDA Submitted for Dry Eye Disease Treatment KPI-121 0.25%